Research and therapeutic approaches in stem cell genome editing by CRISPR toolkit
B Mollashahi, H Latifi-Navid, I Owliaee, S Shamdani… - Molecules, 2023 - mdpi.com
The most widely used genome editing toolkit is CRISPR (clustered regularly interspaced
short palindromic repeats). It provides the possibility of replacing and modifying DNA and …
short palindromic repeats). It provides the possibility of replacing and modifying DNA and …
[PDF][PDF] Next-Generation strategies to combat antimicrobial resistance: Integrating genomics, CRISPR, and novel therapeutics for effective treatment
AO Olatunji, JA Olaboye, CC Maha… - … & Technology Journal, 2024 - researchgate.net
Olatunji, Olaboye, Maha, KOlawole, & Abdul, P. No. 2284-2303 Page 2285 therapy, and
synthetic biology-derived compounds, provides alternative treatment options. These …
synthetic biology-derived compounds, provides alternative treatment options. These …
Genome-scale CRISPR-Cas9 screening in stem cells: theories, applications and challenges
Due to the rapid development of stem cell technology, there have been tremendous
advances in molecular biological and pathological research, cell therapy as well as …
advances in molecular biological and pathological research, cell therapy as well as …
Insertion-and-deletion mutations between the genomes of SARS-CoV, SARS-CoV-2, and bat coronavirus RaTG13
T Akaishi - Microbiology spectrum, 2022 - Am Soc Microbiol
The evolutional process of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
development remains inconclusive. This study compared the genome sequences of severe …
development remains inconclusive. This study compared the genome sequences of severe …
The Evolution of Genome‐Editing Technologies
The evolution of genome‐editing technologies refers to the development and advancement
of techniques used to modify the DNA of an organism. These technologies have rapidly …
of techniques used to modify the DNA of an organism. These technologies have rapidly …
The CRISPR/Cas9-mediated base editing design of HBV specific gRNA: A computational approach
H Yuliawuri, JE Christian, EA Suherman - AIP Conference …, 2024 - pubs.aip.org
Therapy to cure a persistent infection of the Hepatitis B Virus (HBV) is needed to suppress
viral replication. Current therapy with nucleoside analogues does not destroy HBV …
viral replication. Current therapy with nucleoside analogues does not destroy HBV …
[引用][C] CRISPR challenges in clinical developments
M Khoshandam, H Soltaninejad, I Bhia, MTH Goudarzi… - 2024 - Elsevier